Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharma Stocks In News - Weekly Roundup
RTT News
Saturday, May 1, 2010 - 11:24am
tags:
drug stocks
Celtic Pharma Announces Initiation Of Phase III Trial Of TDT 067 For The Treatment Of Onychomycosis
Medical News Today
Saturday, May 1, 2010 - 11:13am
tags:
Celtic Pharmaceutical Holdings, Onychomycosis
Aton Pharma Acquires Parkinson's Drug LODOSYN(R) (carbidopa)
Medical News Today
Saturday, May 1, 2010 - 11:11am
tags:
Aton Pharma, LODOSYN, carbidopa, Parkinson's Disease
Foamix Receives a New U.S. Patent for Its Emollient and Aqueous Foam Technology
PR.com
Saturday, May 1, 2010 - 11:09am
tags:
Foamix, drug delivery
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra® ( lopinavir / ritonavir ) for Treatment-Experienced Patients
Vadvdert
Saturday, May 1, 2010 - 11:03am
tags:
Abbott Laboratories, Kaletra, HIV
Newspaper (in Brazil): Pfizer to purchase Brazil drug company
Yahoo/AP
Saturday, May 1, 2010 - 10:58am
tags:
Pfizer, Laboratorio Teuto Brasileiro
GlaxoSmithKline On Simmer
Investopedia
Saturday, May 1, 2010 - 10:53am
tags:
GSK
The Drug Stock Sell-Off
Forbes
Saturday, May 1, 2010 - 10:52am
tags:
drug stocks
Patent Losses Trump ObamaCare Benefits
Investor's Business Daily
Saturday, May 1, 2010 - 10:47am
tags:
patents, Merck, Teva Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly
Pozen shares take wild ride before FDA decision
bizjournals.com
Saturday, May 1, 2010 - 10:45am
tags:
Pozen, Vimovo, arthritis
Cyclacel Receives Complaint Filed by Celgene Seeking to Avoid Certain Cyclacel Patents
Yahoo/Global NewsWire
Saturday, May 1, 2010 - 10:35am
tags:
Cyclacel, romidepsin, Celgene, T-cell lymphoma
MannKind Corporation Q1 2010 Earnings Call Transcript
Seeking Alpha
Saturday, May 1, 2010 - 10:33am
tags:
MannKind, earnings
Acorda Therapeutics, Inc. Q1 2010 Earnings Call Transcript
Seeking Alpha
Saturday, May 1, 2010 - 10:31am
tags:
Acorda Therapeutics
Dendreon: Yes, It Got FDA Approval, But Here's What It Did Wrong
Seeking Alpha
Saturday, May 1, 2010 - 10:27am
tags:
Dendreon, Provenge
The Next Biotech Drug to Watch: InterMune’s Pirfenidone
Minyanville
Saturday, May 1, 2010 - 10:23am
tags:
InterMune, pirfenidone, idiopathic pulmonary fibrosis
Living the Blockbuster Model
Motley Fool
Friday, April 30, 2010 - 3:49pm
tags:
GSK, AstraZeneca, Sanofi, Eli Lilly
Earnings Preview: Pfizer to report 1Q results
Yahoo/AP
Friday, April 30, 2010 - 3:43pm
tags:
earnings, Pfizer
Pozen shares sink ahead of FDA decision
Marketwatch
Friday, April 30, 2010 - 3:38pm
tags:
vivmo, Pozen, FDA, AstraZeneca
Bristol Myers Still Rocks
Motley Fool
Friday, April 30, 2010 - 3:33pm
tags:
Bristol-Myers Squibb
Appeals Court Upholds Pay-For-Delay Deals
Pharmalot
Friday, April 30, 2010 - 8:59am
tags:
pay-for-delay, FTC

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.